Study of Difluoromethylornithine (DFMO) in Combination With Bortezomib for Relapsed or Refractory Neuroblastoma
Clinical trial NCT02139397 · COMPLETED
Trial details
- NCT number
- NCT02139397
- Sponsor
- Giselle Sholler
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-06
- Primary completion
- 2024-01-19
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.